Pulmonary artery stent thrombosis and symptomatic pulmonary hypertension following COVID-19 infection in Alagille patient: A case report
In the era of COVID-19, patients with pulmonary vascular malformations and endovascular stents are at an increased risk for chronic thromboembolic disease. Patients may benefit from prophylactic antiplatelet or anticoagulation therapy. Stent thrombosis is a devastating phenomenon and should be treated urgently and aggressively with balloon pulmonary angioplasty, and/or a thrombolytic agent.
Authors
- Mordechai Reuven Kramer (ORCID: https://orcid.org/0000-0003-2376-2393)
- Shimon Izhakian (ORCID: https://orcid.org/0000-0003-1150-1057)
- Elchanan Bruckheimer (ORCID: https://orcid.org/0000-0002-5454-6805)
- Dror Rosengarten (ORCID: https://orcid.org/0000-0003-1754-5878)
- Miriam Korlansky
Institutions
- Rabin Medical Center (IL)
- Schneider Children's Medical Center (IL)
Publication Details
- Journal
- World Journal of Clinical Cases
- Published
- 2024-12-11
- DOI
- https://doi.org/10.12998/wjcc.v13.i9.96897
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00